Santa K, Tamaki R, Watanabe K, Nagaoka I
Front Nutr. 2024; 11:1465324.
PMID: 39434894
PMC: 11492870.
DOI: 10.3389/fnut.2024.1465324.
Vajdi M, Karimi A, Hassanizadeh S, Farhangi M, Bagherniya M, Askari G
Pharmacol Rep. 2024; 76(2):307-327.
PMID: 38498260
DOI: 10.1007/s43440-024-00585-6.
Pavlidou E, Poulios E, Papadopoulou S, Fasoulas A, Dakanalis A, Giaginis C
Med Sci (Basel). 2024; 12(1).
PMID: 38390861
PMC: 10885051.
DOI: 10.3390/medsci12010011.
Brown K, Theofanous D, Britton R, Aburido G, Pepper C, Sri Undru S
Int J Mol Sci. 2024; 25(2).
PMID: 38255828
PMC: 10815776.
DOI: 10.3390/ijms25020747.
Lou P, Fang A, Zhao W, Yao K, Yang Y, Hu J
J Med Internet Res. 2023; 25:e45225.
PMID: 37862061
PMC: 10592722.
DOI: 10.2196/45225.
Comparison of Vitamin D and Resveratrol Performances in COVID-19.
Russo C, Valle M, Malaguarnera L, Romano I, Malaguarnera L
Nutrients. 2023; 15(11).
PMID: 37299603
PMC: 10255599.
DOI: 10.3390/nu15112639.
Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets.
Lopez-Cortes G, Palacios-Perez M, Hernandez-Aguilar M, Velediaz H, Jose M
Vaccines (Basel). 2023; 11(1).
PMID: 36680018
PMC: 9862439.
DOI: 10.3390/vaccines11010174.
Suppression of porcine hemagglutinating encephalomyelitis virus replication by resveratrol.
Liu Y, Song D, Liu X, Wang Y, Wang G, Lan Y
Virol J. 2022; 19(1):226.
PMID: 36578037
PMC: 9795454.
DOI: 10.1186/s12985-022-01953-5.
Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules.
Bondarev A, Attwood M, Jonsson J, Chubarev V, Tarasov V, Liu W
Front Pharmacol. 2022; 13:1057083.
PMID: 36506513
PMC: 9731127.
DOI: 10.3389/fphar.2022.1057083.
Antioxidant Effects of Dietary Supplements on Adult COVID-19 Patients: Why Do We Not Also Use Them in Children?.
Notarbartolo V, Montante C, Ferrante G, Giuffre M
Antioxidants (Basel). 2022; 11(9).
PMID: 36139712
PMC: 9495518.
DOI: 10.3390/antiox11091638.
Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases.
Zhai Z, Huang Y, Zhang Y, Zhao L, Li W
Antioxidants (Basel). 2022; 11(8).
PMID: 36009283
PMC: 9405369.
DOI: 10.3390/antiox11081564.
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.
Clerbaux L, Albertini M, Amigo N, Beronius A, Bezemer G, Coecke S
J Clin Med. 2022; 11(15).
PMID: 35956081
PMC: 9369763.
DOI: 10.3390/jcm11154464.
Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y, Deng S, Bai Y, Guo J, Kai G, Huang X
Phytother Res. 2022; 36(10):3833-3858.
PMID: 35932157
PMC: 9538226.
DOI: 10.1002/ptr.7580.
Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review.
Barber T, Kabisch S, Randeva H, Pfeiffer A, Weickert M
Nutrients. 2022; 14(14).
PMID: 35889827
PMC: 9320680.
DOI: 10.3390/nu14142870.
COVID-19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances.
Belchior-Bezerra M, Lima R, Medeiros N, Gomes J
Obes Rev. 2022; 23(10):e13496.
PMID: 35837843
PMC: 9349458.
DOI: 10.1111/obr.13496.
How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection.
Kielbowski K, Herian M, Pawlik A
Int J Mol Sci. 2022; 23(12).
PMID: 35742820
PMC: 9223498.
DOI: 10.3390/ijms23126377.
Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges.
Yusuf A, Zhang J, Li J, Muhammad A, Abubakar M
Phytomed Plus. 2022; 2(3):100280.
PMID: 35463625
PMC: 9014648.
DOI: 10.1016/j.phyplu.2022.100280.
Post-COVID Complications after Pressure Ulcer Surgery in Patients with Spinal Cord Injury Associate with Creatine Kinase Upregulation in Adipose Tissue.
Martinez-Torija M, Esteban P, Espino-Rodriguez F, Paniagua-Torija B, Molina-Holgado E, Ceruelo S
Cells. 2022; 11(8).
PMID: 35455962
PMC: 9025224.
DOI: 10.3390/cells11081282.
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.
Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C
Front Pharmacol. 2022; 13:835136.
PMID: 35250581
PMC: 8894812.
DOI: 10.3389/fphar.2022.835136.
The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator's perspective.
van Brummelen R, van Brummelen A
Biomed Pharmacother. 2022; 148:112767.
PMID: 35240527
PMC: 8884665.
DOI: 10.1016/j.biopha.2022.112767.